EP0797592A4 - Menschliches stanniocalcin-alpha - Google Patents

Menschliches stanniocalcin-alpha

Info

Publication number
EP0797592A4
EP0797592A4 EP95904073A EP95904073A EP0797592A4 EP 0797592 A4 EP0797592 A4 EP 0797592A4 EP 95904073 A EP95904073 A EP 95904073A EP 95904073 A EP95904073 A EP 95904073A EP 0797592 A4 EP0797592 A4 EP 0797592A4
Authority
EP
European Patent Office
Prior art keywords
alpha
human stanniocalcin
stanniocalcin
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95904073A
Other languages
English (en)
French (fr)
Other versions
EP0797592A1 (de
Inventor
Henrik Olsen
Robert D Fleischmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP0797592A1 publication Critical patent/EP0797592A1/de
Publication of EP0797592A4 publication Critical patent/EP0797592A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP95904073A 1994-11-10 1994-11-10 Menschliches stanniocalcin-alpha Withdrawn EP0797592A4 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/013206 WO1996015147A1 (en) 1994-11-10 1994-11-10 Human stanniocalcin-alpha

Publications (2)

Publication Number Publication Date
EP0797592A1 EP0797592A1 (de) 1997-10-01
EP0797592A4 true EP0797592A4 (de) 1999-10-20

Family

ID=22243284

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95904073A Withdrawn EP0797592A4 (de) 1994-11-10 1994-11-10 Menschliches stanniocalcin-alpha

Country Status (6)

Country Link
EP (1) EP0797592A4 (de)
JP (1) JPH10509036A (de)
KR (1) KR100432260B1 (de)
AU (1) AU687962B2 (de)
NZ (1) NZ277605A (de)
WO (1) WO1996015147A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008322A (en) * 1996-04-02 1999-12-28 Zymogenetics, Inc. Stanniocalcin-2
US6538119B2 (en) * 1997-11-18 2003-03-25 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
EP1070758B1 (de) * 1998-04-10 2007-05-30 Daiichi Pharmaceutical Co., Ltd. Menschliches stanniocalcin und seine verwendung zur hemmung der adipogenese
JP3524536B2 (ja) 1999-11-04 2004-05-10 ディアデクサス インコーポレーテッド 癌の診断、モニタリング、ステージング、イメージングおよび処置のための新規方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024411A1 (en) * 1994-03-08 1995-09-14 Human Genome Sciences, Inc. Corpuscles of stannius protein, stanniocalcin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003949A1 (en) * 1986-11-21 1988-06-02 Howard Florey Institute Of Experimental Physiology The cs protein of the corpuscles of stannius

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024411A1 (en) * 1994-03-08 1995-09-14 Human Genome Sciences, Inc. Corpuscles of stannius protein, stanniocalcin

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BUTKUS A ET AL: "PURIFICATION AND CLONING OF A CORPUSCLES OF STANNIUS PROTEIN FROM ANGUILLA AUSTRALIS", MOLECULAR AND CELLULAR ENDOCRINOLOGY, vol. 54, no. 2/03, 1 December 1987 (1987-12-01), pages 123 - 133, XP000605664, ISSN: 0303-7207 *
See also references of WO9615147A1 *
WAGNER G F ET AL: "MOLECULAR CLONING AND CDNA SEQUENCE ANALYSIS OF COHO SALMON STANNIOCALCIN", MOLECULAR AND CELLULAR ENDOCRINOLOGY, vol. 90, no. 1, 1 December 1992 (1992-12-01), pages 7 - 15, XP000605660, ISSN: 0303-7207 *

Also Published As

Publication number Publication date
NZ277605A (en) 1999-03-29
WO1996015147A1 (en) 1996-05-23
EP0797592A1 (de) 1997-10-01
AU687962B2 (en) 1998-03-05
JPH10509036A (ja) 1998-09-08
KR100432260B1 (ko) 2004-09-16
AU1289695A (en) 1996-06-06
KR970707155A (ko) 1997-12-01

Similar Documents

Publication Publication Date Title
PL328822A1 (en) Human bikinine
ZA959218B (en) Skin engaging member
EP0713672A3 (de) Endoskop
GB9411080D0 (en) Treatment
DE59503739D1 (en) Polymer-sensor
DE69502271D1 (en) Afterabtrennung
ZA9533B (en) Pentolifylline therapy
DE59503634D1 (en) Friercontainer
DE69429543D1 (en) Koagulationszange
EP0774916A4 (de) Endoskop
GB9414157D0 (en) Medical use
DE59509661D1 (en) Heterocyclylbenzonitrile
AU122938S (en) Breadbox
EP0764204A4 (de) HUMANE OXALYL-CoA DECARBOXYLASE
EP0797592A4 (de) Menschliches stanniocalcin-alpha
ZA947865B (en) Human glactokinase
DE59508136D1 (en) Phenylthio-oxazolin-derivate
EP0795006A4 (de) MENSCHLICHES MuT2
GB9617550D0 (en) Medical ice-pack
ZA949714B (en) Human MutT2
HU9502355D0 (en) Human interleukin-6-inhibitor
DE59510739D1 (en) N-cyanoaryl-stickstoffheterocyclen
DE59503452D1 (en) Piezoresistiver widerstand
CA73798S (en) Air-purifier
CA73835S (en) Air-purifier

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970610

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 6C 12N 15/16 A, 6C 12N 5/10 B, 6C 07K 14/575 B, 6C 07K 14/585 B, 6C 07K 16/26 B, 6A 61K 38/22 B, 6G 01N 33/50 B, 6C 12Q 1/68 B

A4 Supplementary search report drawn up and despatched

Effective date: 19990906

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20020125

RIN1 Information on inventor provided before grant (corrected)

Inventor name: FLEISCHMANN, ROBERT D.

Inventor name: OLSEN, HENRIK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060531